HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

Lymphoma

Lymphoma

We’re here for you. Call us at 844-346-7222 or

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.

60 Clinical Trials
Lymphoma NA Accepting Patients
nct/study# NA / 2020-1089

Comparison Of Clinical Trials Enrollment In Patient Records And Claims

Learn More
Lymphoma Phase II Accepting Patients
nct/study# NCT04268706 / TESSCAR001

A Phase 2 Multi-Center Study Evaluating The Safety And Efficacy Of CD30-Directed Genetically Modified Autologous T Cells (CD30.CAR-T) In Adult And Pediatric Patients With Relapsed Or Refractory CD30 Positive Classical Hodgkin Lymphoma (CHARIOT TESSCAR001)

Learn More
Lymphoma Phase I Accepting Patients
nct/study# NCT04277637 / BGB-11417-101

A Phase 1/1b Open-Label Dose Escalation And Expansion Study Of Bcl-2 Inhibitor BGB-11417 In Patients With Mature B-Cell Malignancies

Learn More
Lymphoma Phase I Accepting Patients
nct/study# NCT02663518 / TTI-621-01

A Phase 1a/1b Dose Escalation And Expansion Trial Of TTI-621, A Novel Biologic Targeting CD47, In Subjects With Relapsed Or Refractory Hematologic Malignancies And Selected Solid Tumors

Learn More
Lymphoma Phase II Accepting Patients
nct/study# NCT04116437 / BGB-3111-215

A Phase 2, Multicenter, Single-Arm Study Of Zanubrutinib (BGB-3111) In Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant Of Prior Treatment With Ibrutinib

Learn More
Lymphoma NA Accepting Patients
nct/study# NA / 2021-0552

Outcomes Of Patients With T-Cell Lymphoma With Central Nervous System Relapse

Learn More

We are here for you

For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.